These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27979006)

  • 1. Comparing Prostate Cancer Treatment Decision Making in a Resource-rich and a Resource-poor Environment: A Tale of two Hospitals.
    Walker DM; McAlearney AS; Sova LN; Lin JJ; Abramson S; Bickell NA
    J Natl Med Assoc; 2016; 108(4):211-219. PubMed ID: 27979006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative study to understand guideline-discordant use of imaging to stage incident prostate cancer.
    Makarov DV; Sedlander E; Braithwaite RS; Sherman SE; Zeliadt S; Gross CP; Curnyn C; Shedlin M
    Implement Sci; 2016 Sep; 11(1):118. PubMed ID: 27590603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Is a "Good" Treatment Decision? Decisional Control, Knowledge, Treatment Decision Making, and Quality of Life in Men with Clinically Localized Prostate Cancer.
    Orom H; Biddle C; Underwood W; Nelson CJ; Homish DL
    Med Decis Making; 2016 Aug; 36(6):714-25. PubMed ID: 26957566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.
    Orom H; Homish DL; Homish GG; Underwood W
    Urol Oncol; 2014 May; 32(4):396-402. PubMed ID: 24332649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study.
    Guan A; Santiago-Rodríguez EJ; Chung BI; Shim JK; Allen L; Kuo MC; Lau K; Loya Z; Brooks JD; Cheng I; DeRouen MC; Frosch DL; Golden T; Leppert JT; Lichtensztajn DY; Lu Q; Oh D; Sieh W; Wadhwa M; Cooperberg MR; Carroll PR; Gomez SL; Shariff-Marco S
    BMC Cancer; 2023 Dec; 23(1):1191. PubMed ID: 38053037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative approach to understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer in Massachusetts.
    Labban M; Stone BV; Steele GL; Salinas KE; Agudile E; Katz MH; Rihan-Porter N; Reich AJ; Cole AP; Landers S; Trinh QD
    Cancer; 2024 Oct; 130 Suppl 20():3590-3601. PubMed ID: 38837334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision-making Processes among Prostate Cancer Survivors with Rising PSA Levels: Results from a Qualitative Analysis.
    Shen MJ; Nelson CJ; Peters E; Slovin SF; Hall SJ; Hall M; Herrera PC; Leventhal EA; Leventhal H; Diefenbach MA
    Med Decis Making; 2015 May; 35(4):477-86. PubMed ID: 25385751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment.
    Holmes-Rovner M; Montgomery JS; Rovner DR; Scherer LD; Whitfield J; Kahn VC; Merkle EC; Ubel PA; Fagerlin A
    Med Decis Making; 2015 Nov; 35(8):999-1009. PubMed ID: 26304063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current decision-making in prostate cancer therapy.
    Cox J; Amling CL
    Curr Opin Urol; 2008 May; 18(3):275-8. PubMed ID: 18382237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study.
    Subramanian L; Hawley ST; Skolarus TA; Rankin A; Fetters MD; Witzke K; Chen J; Radhakrishnan A
    Cancer Med; 2024 Jan; 13(1):e6847. PubMed ID: 38151901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer treatment decisions: a focus group exploration.
    O'Rourke ME; Germino BB
    Oncol Nurs Forum; 1998; 25(1):97-104. PubMed ID: 9460777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative study on decision-making by prostate cancer physicians during active surveillance.
    Loeb S; Curnyn C; Fagerlin A; Braithwaite RS; Schwartz MD; Lepor H; Carter HB; Sedlander E
    BJU Int; 2017 Jul; 120(1):32-39. PubMed ID: 27611479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer as part of the journey: the role of spirituality in the decision to decline conventional prostate cancer treatment and to use complementary and alternative medicine.
    White M; Verhoef M
    Integr Cancer Ther; 2006 Jun; 5(2):117-22. PubMed ID: 16685076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy.
    Ihrig A; Keller M; Hartmann M; Debus J; Pfitzenmaier J; Hadaschik B; Hohenfellner M; Herzog W; Huber J
    BJU Int; 2011 Oct; 108(8):1274-8. PubMed ID: 21410634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnographic investigation of patient-provider communication among African American men newly diagnosed with prostate cancer: a study protocol.
    Palmer NR; Shim JK; Kaplan CP; Schillinger D; Blaschko SD; Breyer BN; Pasick RJ
    BMJ Open; 2020 Aug; 10(8):e035032. PubMed ID: 32759241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a patient decision aid for men with localized prostate cancer: evaluation of patient outcomes and practice variation.
    Stacey D; Taljaard M; Smylie J; Boland L; Breau RH; Carley M; Jana K; Peckford L; Blackmore T; Waldie M; Wu RC; Legare F
    Implement Sci; 2016 Jul; 11(1):87. PubMed ID: 27368830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancer.
    Guan A; Shim JK; Allen L; Kuo MC; Lau K; Loya Z; Brooks JD; Carroll PR; Cheng I; Chung BI; DeRouen MC; Frosch DL; Golden T; Leppert JT; Lichtensztajn DY; Lu Q; Oh DL; Sieh W; Wadhwa M; Gomez SL; Shariff-Marco S
    Cancer Med; 2023 Mar; 12(5):6307-6317. PubMed ID: 36404625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.